Correlation Between Shattuck Labs and Champions Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shattuck Labs and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shattuck Labs and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shattuck Labs and Champions Oncology, you can compare the effects of market volatilities on Shattuck Labs and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shattuck Labs with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shattuck Labs and Champions Oncology.

Diversification Opportunities for Shattuck Labs and Champions Oncology

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Shattuck and Champions is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Shattuck Labs and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Shattuck Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shattuck Labs are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Shattuck Labs i.e., Shattuck Labs and Champions Oncology go up and down completely randomly.

Pair Corralation between Shattuck Labs and Champions Oncology

Given the investment horizon of 90 days Shattuck Labs is expected to under-perform the Champions Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Shattuck Labs is 1.22 times less risky than Champions Oncology. The stock trades about -0.01 of its potential returns per unit of risk. The Champions Oncology is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest  820.00  in Champions Oncology on November 3, 2024 and sell it today you would earn a total of  279.00  from holding Champions Oncology or generate 34.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Shattuck Labs  vs.  Champions Oncology

 Performance 
       Timeline  
Shattuck Labs 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Shattuck Labs are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady basic indicators, Shattuck Labs may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Champions Oncology 

Risk-Adjusted Performance

23 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Champions Oncology are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating fundamental drivers, Champions Oncology reported solid returns over the last few months and may actually be approaching a breakup point.

Shattuck Labs and Champions Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shattuck Labs and Champions Oncology

The main advantage of trading using opposite Shattuck Labs and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shattuck Labs position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.
The idea behind Shattuck Labs and Champions Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm